rs200894246

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The c.2413G>A (p.Asp805Asn) variant has an allele frequency of 0.00207 (0.21%, 21/10,148 alleles) in the Ashkenazi Jewish subpopulation of the gnomAD cohort (BA1). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA157966/MONDO:0007648/007

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 0 hom. )

Consequence

CDH1
NM_004360.5 missense

Scores

5
5
8

Clinical Significance

Benign reviewed by expert panel U:2B:20O:2

Conservation

PhyloP100: 5.80

Publications

17 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), G2P
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.2413G>Ap.Asp805Asn
missense
Exon 15 of 16NP_004351.1
CDH1
NM_001317184.2
c.2230G>Ap.Asp744Asn
missense
Exon 14 of 15NP_001304113.1
CDH1
NM_001317185.2
c.865G>Ap.Asp289Asn
missense
Exon 15 of 16NP_001304114.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.2413G>Ap.Asp805Asn
missense
Exon 15 of 16ENSP00000261769.4
CDH1
ENST00000422392.6
TSL:1
c.2230G>Ap.Asp744Asn
missense
Exon 14 of 15ENSP00000414946.2
CDH1
ENST00000562836.5
TSL:1
n.2484G>A
non_coding_transcript_exon
Exon 14 of 15

Frequencies

GnomAD3 genomes
AF:
0.000257
AC:
39
AN:
151890
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000591
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.000481
GnomAD2 exomes
AF:
0.000239
AC:
60
AN:
251276
AF XY:
0.000162
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00198
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000211
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000243
AC:
355
AN:
1461840
Hom.:
0
Cov.:
32
AF XY:
0.000223
AC XY:
162
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.000447
AC:
20
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00187
AC:
49
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53390
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.000228
AC:
254
AN:
1111990
Other (OTH)
AF:
0.000331
AC:
20
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000257
AC:
39
AN:
151890
Hom.:
0
Cov.:
32
AF XY:
0.000270
AC XY:
20
AN XY:
74158
show subpopulations
African (AFR)
AF:
0.0000484
AC:
2
AN:
41350
American (AMR)
AF:
0.000591
AC:
9
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4806
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000294
AC:
20
AN:
67990
Other (OTH)
AF:
0.000481
AC:
1
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000332
Hom.:
0
Bravo
AF:
0.000325
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000222
AC:
27
EpiCase
AF:
0.000273
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
5
Hereditary diffuse gastric adenocarcinoma (6)
-
1
4
Hereditary cancer-predisposing syndrome (5)
-
-
4
not specified (5)
-
-
3
not provided (3)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
CDH1-related diffuse gastric and lobular breast cancer syndrome (1)
-
-
1
CDH1-related disorder (1)
-
-
1
Malignant tumor of breast (1)
-
-
-
Familial cancer of breast;C1708349:Hereditary diffuse gastric adenocarcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.28
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.31
T
Eigen
Pathogenic
0.70
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.53
D
MetaRNN
Benign
0.23
T
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Benign
1.7
L
PhyloP100
5.8
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-2.6
D
REVEL
Uncertain
0.37
Sift
Benign
0.049
D
Sift4G
Benign
0.12
T
Polyphen
1.0
D
Vest4
0.52
MVP
0.94
MPC
0.89
ClinPred
0.19
T
GERP RS
6.0
Varity_R
0.22
gMVP
0.67
Mutation Taster
=42/58
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200894246; hg19: chr16-68863674; API